Io Biotech (IOBTQ) Stock Price, News & Analysis
Company Description
For FY2025, Io Biotech reported net income of -$95.5M and diluted earnings per share of $-1.45.
This page collects what Stock Titan holds for IOBTQ, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Io Biotech (IOBTQ) last closed at $0.0003.
IOBTQ Rankings
Latest News
SEC Filings
Io Biotech has filed 4 recent SEC filings, including 2 Form SCHEDULE 13G/A, 1 Form 25-NSE, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on June 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all IOBTQ SEC filings →
Financial Highlights
operating income reached -$95.2M, and net income was -$95.5M. Diluted earnings per share stood at $-1.45. The company generated -$82.3M in operating cash flow. With a current ratio of 3.33, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Io Biotech (IOBTQ) currently stands at 490.9 thousand shares, down 14.4% from the previous reporting period, representing 0.7% of the float. Since April 2026, short interest has decreased by 33.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Io Biotech (IOBTQ) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.